900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Intact parathyrin	Parathyroid hormone
Intake process	The act of putting or inserting an object AND/OR substance into or onto the body.
Integreret muskuloskeletal løsning	A treatment strategy where the initial movements are indirect; as the technique is completed the movements change to direct forces; A manipulative sequence involving two or more different osteopathic manipulative treatment method (e.g., Spencer technique combined with muscle energy technique).
Intellectual disability with cataract and kyphosis syndrome	SRD5A3-CDG is a rare, non X-linked congenital disorder of glycosylation due to steroid 5 alpha reductase type 3 deficiency characterized by a highly variable phenotype typically presenting with severe visual impairment, variable ocular anomalies (such as optic nerve hypoplasia/atrophy, iris and optic nerve coloboma, congenital cataract, glaucoma), intellectual disability, cerebellar abnormalities, nystagmus, hypotonia, ataxia, and/or ichthyosiform skin lesions. Other reported manifestations include retinitis pigmentosa, kyphosis, congenital heart defects, hypertrichosis and abnormal coagulation.
Intentional X-ray contrast media overdose	Intentional X-ray diagnostic contrast media overdose
Intentional X-ray contrast media poisoning	Intentional X-ray diagnostic contrast media overdose
tilsigtet overdosis af antabus	Intentional disulfiram overdose (disorder)
tilsigtet forgiftning med antabus	Intentional disulfiram poisoning (disorder)
Intentional chlorprothixene overdose	Intentional chlorprothixene overdose (disorder)
tilsigtet overdosis af natriumvalproat	Intentional valproate overdose (disorder)
Intentional pesticide product overdose	Intentional pesticide product poisoning
tilsigtet overdosis af natriumfusidat	Intentional fusidic acid overdose
tilsigtet overdosis af warfarinnatrium	Intentional warfarin overdose (disorder)
Intentional zuclopenthixol overdose	Intentional chlorprothixene overdose (disorder)
Interdigital pilonidal sinus	Barber's pilonidal sinus
interferon alfa-2b 10 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas	Interferon alfa-2b only product in parenteral dose form
Interferon alfa-2b 10million iu powder for injection solution vial	Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 10 MIE/ml injektionsvæske, opløsning, hætteglas a 2,5 ml	Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug)
interferon alfa-2b 18 MIE/opløsning, hætteglas	Interferon alfa-2b only product
Interferon alfa-2b 18million/iu solution	Interferon alfa-2b only product
Interferon alfa-2b 18mu/vial	Interferon alfa-2b only product
interferon alfa-2b 25 MIE/opløsning, hætteglas	Interferon alfa-2b only product
interferon alfa-2b 3 MIE/opløsning, hætteglas	Interferon alfa-2b only product
interferon alfa-2b 30 MIE opløsning	Interferon alfa-2b only product
interferon alfa-2b 3 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas	Interferon alfa-2b only product in parenteral dose form
Interferon alfa-2b 3million iu powder for injection solution vial	Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 5 MIE/opløsning, hætteglas	Interferon alfa-2b only product
interferon alfa-2b 5 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas	Interferon alfa-2b only product in parenteral dose form
Interferon alfa-2b 5million iu powder for injection solution vial	Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 60 MIE/IE opløsning	Interferon alfa-2b only product
interferon alfa-n3 humant leu 5 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml	Product containing precisely interferon alfa-n3 5 million unit/1 milliliter conventional release solution for injection (clinical drug)
interferon beta-1a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml	Interferon beta-1a 30 microgram/mL solution for injection
interferon beta-1a 24 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml	Interferon beta-1a 24 million unit/mL solution for injection
Interferon beta-1a 30mcg/vial injection	Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug)
interferon beta-1a 30 µg injektionsvæske, opløsning, hætteglas	Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug)
interferon beta-1a 6 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas	Interferon beta-1a only product in parenteral dose form
Interferon beta-1a 6million iu powder for injection solution vial	Interferon beta-1a only product in parenteral dose form
interferon beta-1b 100 µg injektionsvæske, opløsning	Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
interferon beta-1b 8 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas	Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
Interferon beta-1b 8million iu powder for injection solution vial	Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
midlertidig rapport	Interim report (record artifact)
Intermediate care hospital for mentally retarded	Intermediate care hospital for intellectual disability
intermediat faktor VIII-fraktion 250 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas	Coagulation factor VIII only product
intermediat faktor VIII-fraktion 500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas	Coagulation factor VIII only product
Angiography of internal carotid arteries, bilateral	Angiography of cervicocerebral arteries
Intermediate lobe of right lung	Structure of middle lobe of right lung (body structure)
Intermediate metabolizer due to cytochrome p450 CYP2C19 variant	CYP2C19 intermediate metabolizer
intermediate metabolizer forårsaget af cytochrom P450 CYP2D6-variant	Cytochrome P450 family 2 subfamily D member 6 intermediate metabolizer (finding)
Intermitterende CPAP	Positive pressure ventilation
Ventilation med intermitterende positivt tryk	Positive pressure ventilation
Intermittent positive pressure ventilation	Positive pressure ventilation
Ventilation med intermitterende overtryk via pose og maske	Positive pressure ventilation via bag and mask (regime/therapy)
Ventilation med intermitterende overtryk via endotrakealtube	Positive pressure ventilation via endotracheal tube
røntgenundersøgelse af meatus acusticus internus	Plain X-ray of internal acoustic meatus of temporal bone (procedure)
intern fiksation af underkæben med fiksationsskinne	External fixation of mandible with arch bars (procedure)
Internal fixation of mandible with arch bars	External fixation of mandible with arch bars (procedure)
Intern fiksering af maxilla, ikke klassificeret andetsteds	Fixation of maxilla - internal
Internal granuloma of pulp	Internal resorption of tooth
Internal haemorrhoids - other	Internal hemorrhoids
interne hæmorider – andre	Internal hemorrhoids
interne hæmorider uden komplikation	Internal hemorrhoids
Internal injury NOS	Injury of body cavity structure
Internal injury NOS	Injury of body cavity structure
intern mammalymfangiografi	Fluoroscopic lymphangiography of internal mammary lymph node group with contrast
Internal metabolic radiotherapy NOS	Radionuclide therapy
Internal metabolic radiotherapy NOS	Radionuclide therapy
Intern migration	Transuterine migration (finding)
Internal oblique flap	Internal oblique muscle flap
Internal resorption of crown of tooth	Internal resorption of tooth
intern støtte, ikke nærmere specificeret	Internal support
Internal support NOS	Internal support
Internal unsealed radiotherapy NOS	Radionuclide therapy
Internal unsealed radiotherapy NOS	Radionuclide therapy
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IA1	American Joint Committee on Cancer stage IA1 (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IA2	American Joint Committee on Cancer stage IA2 (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IB1	American Joint Committee on Cancer stage IB1 (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IB2	American Joint Committee on Cancer stage IB2 (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIA1	American Joint Committee on Cancer stage IIA1 (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIA2	American Joint Committee on Cancer stage IIA2 (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIB	American Joint Committee on Cancer stage IIB (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIIA	American Joint Committee on Cancer stage IIIA (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIIB	American Joint Committee on Cancer stage IIIB (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IVA	American Joint Committee on Cancer stage IVA (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IVB	American Joint Committee on Cancer stage IVB (qualifier value)
FIGO CC stadium 0	Carcinoma in situ of uterine cervix
FIGO CC stadium 1	American Joint Committee on Cancer stage I (qualifier value)
FIGO CC stadium II	American Joint Committee on Cancer stage II (qualifier value)
FIGO CC stadium III	American Joint Committee on Cancer stage III (qualifier value)
FIGO CC stadium IV	American Joint Committee on Cancer stage IV (qualifier value)
FIGO CC stadium 1a	American Joint Committee on Cancer stage IA (qualifier value)
FIGO CC stadium 1b	American Joint Committee on Cancer stage IB (qualifier value)
FIGO CC stadium 1b occ	American Joint Committee on Cancer stage IB (qualifier value)
International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IIIA	American Joint Committee on Cancer stage IIIA (qualifier value)
International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IVA	American Joint Committee on Cancer stage IVA (qualifier value)
International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IVB	American Joint Committee on Cancer stage IVB (qualifier value)
FIGO EC stadium I	American Joint Committee on Cancer stage I (qualifier value)
FIGO EC stadium I A	American Joint Committee on Cancer stage IA (qualifier value)
FIGO EC stadium I B	American Joint Committee on Cancer stage IB (qualifier value)
FIGO EC stadium II	American Joint Committee on Cancer stage II (qualifier value)
FIGO EC stadium III	American Joint Committee on Cancer stage III (qualifier value)
International Federation of Gynecology and Obstetrics endometrial cancer stage IIIB	American Joint Committee on Cancer stage IIIB (qualifier value)

Start Previous Page 96 of 234 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)